Thailand will stop using the Covid-19 vaccine of China's Sinovac when its current stock finishes, a senior official has said, having used the shot extensively in combination with Western-developed vaccines.
“We expect to have distributed all Sinovac doses this week,” said health official Opas Karnkawinpong, adding the programme will switch to combining the AstraZeneca vaccine with that made by Pfizer and BioNTech.
Thailand next year plans to buy 120 million Covid-19 vaccine doses in total and has already booked 60m doses of AstraZeneca, a vaccine it manufactures locally, according to a Reuters report.




























